1. Home
  2. CMCO vs CLLS Comparison

CMCO vs CLLS Comparison

Compare CMCO & CLLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Columbus McKinnon Corporation

CMCO

Columbus McKinnon Corporation

BUY

Current Price

$15.98

Market Cap

483.0M

Sector

Industrials

ML Signal

BUY

Logo Cellectis S.A.

CLLS

Cellectis S.A.

N/A

Current Price

$1.25

Market Cap

394.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CMCO
CLLS
Founded
1875
1999
Country
United States
France
Employees
N/A
N/A
Industry
Construction/Ag Equipment/Trucks
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
483.0M
394.4M
IPO Year
2002
2014

Fundamental Metrics

Financial Performance
Metric
CMCO
CLLS
Price
$15.98
$1.25
Analyst Decision
Buy
Buy
Analyst Count
4
5
Target Price
★ $26.00
$5.33
AVG Volume (30 Days)
★ 340.5K
186.3K
Earning Date
10-29-2026
11-06-2026
Dividend Yield
★ 1.73%
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $936,240,000.00
N/A
Revenue This Year
$76.00
N/A
Revenue Next Year
$4.04
$10.70
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 3.27
N/A
52 Week Low
$11.99
$1.25
52 Week High
$24.40
$5.48

Technical Indicators

Market Signals
Indicator
CMCO
CLLS
Relative Strength Index (RSI) 44.41 21.98
Support Level $14.88 N/A
Resistance Level $16.42 $2.99
Average True Range (ATR) 0.70 0.08
MACD 0.04 0.02
Stochastic Oscillator 36.18 6.73

Price Performance

Historical Comparison
CMCO
CLLS

About CMCO Columbus McKinnon Corporation

Columbus McKinnon Corp is a world-wide designer, manufacturer and marketer of intelligent motion solutions for material handling that move the world forward and improve lives by efficiently and ergonomically moving, lifting, positioning and securing materials. Its key products include hoists, crane components, precision conveyor systems, rigging tools, light rail workstations and digital power and motion control systems. These are relevant, professional-grade solutions that solve its customers critical material handling requirements. The company has one operating and reportable segment. It has presence in United State, Germany, Europe, Middle East, and Africa (Excluding Germany), Canada, Asia Pacific, and Latin America. It has majority of sales from United States.

About CLLS Cellectis S.A.

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.

Share on Social Networks: